Primary Care/Hospitalist
RSSArticles
-
Pharmacology Watch: Women's Health Issue — Adverse Medication Effects
In this issue: Calcium supplements and MI; birth control pills and VTE; ACE inhibitors and breast cancer risk; spending on pharmaceuticals; and FDA actions. -
Abstract & Commentary: Treatment of HHV-8-related Disease with Antivirals
Uldrick et al performed a pilot study in which 14 HIV-infected patients with symptomatic MCD received high-dose AZT (600 mg PO Q6 hours) and VGC (900 mg PO Q12 hours). -
Spending on U.S. pharmaceuticals
-
Birth control pills and VTE risk
-
Calcium supplements and MI risk
-
Pharmacology Watch - Full June 2011 Issue in PDF
-
FDA actions
-
ACE inhibitors and breast cancer risk
-
Updates By Carol A. Kemper, MD, FACP
Coccidioidal infections are always unique the travel history often provides the right clue for the practitioner but first you have to think to ask the right question. -
Abstract & Commentary: cART Start
In a prospective observational study, investigators of the HIV-CAUSAL Collaboration evaluated data from participating HIV clinics in Europe and the U.S. Veterans Administration system to determine the optimal CD4+ T cell count at which combination antiretroviral therapy (cART) should be initiated.